다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Addex Therapeutics Ltd (ADXN)
Addex Therapeutics Ltd (ADXN) 뉴스

ADXN

Addex Therapeutics (ADXN)

Addex Therapeutics Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ADXN

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/08	14:00	GlobeNewswire Inc.	Addex to Present at Bio€quity Europe 2024	NASDAQ:ADXN	Addex Therapeutics Ltd
2024/04/29	14:00	GlobeNewswire Inc.	Addex Provides Update on ADX71149 Phase 2 Epilepsy Study	NASDAQ:ADXN	Addex Therapeutics Ltd
2024/04/19	14:00	GlobeNewswire Inc.	Addex to Present at the Swiss Biotech Day 2024	NASDAQ:ADXN	Addex Therapeutics Ltd
2024/04/18	14:00	GlobeNewswire Inc.	Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:ADXN	Addex Therapeutics Ltd
2024/04/11	14:00	GlobeNewswire Inc.	Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024	NASDAQ:ADXN	Addex Therapeutics Ltd
2024/04/03	14:00	GlobeNewswire Inc.	Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders	NASDAQ:ADXN	Addex Therapeutics Ltd
2024/03/14	15:00	GlobeNewswire Inc.	Addex to Present at the Bio-Europe Spring 2024 Conference	NASDAQ:ADXN	Addex Therapeutics Ltd
2024/01/31	15:00	GlobeNewswire Inc.	Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.	NASDAQ:ADXN	Addex Therapeutics Ltd
2024/01/31	07:00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ADXN	Addex Therapeutics Ltd
2024/01/31	06:58	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ADXN	Addex Therapeutics Ltd
2024/01/09	15:00	GlobeNewswire Inc.	Addex to Present at the Swiss Equities Baader Conference	NASDAQ:ADXN	Addex Therapeutics Ltd
2024/01/05	15:30	GlobeNewswire Inc.	Addex to Present at Biotech Showcase™ 2024	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/12/21	20:00	Edgar (US Regulatory)	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/12/20	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/12/20	15:00	GlobeNewswire Inc.	Addex Shareholders Approve All Resolutions at Extraordinary General Meeting	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/12/14	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/12/14	15:00	GlobeNewswire Inc.	Addex Creates Treasury Shares	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/12/09	04:11	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/12/01	06:00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/11/30	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/11/30	06:00	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/11/29	20:27	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/11/29	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/11/29	15:00	GlobeNewswire Inc.	Addex Reports Q3 2023 Financial Results and Provides Corporate Update	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/11/28	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/11/28	15:00	GlobeNewswire Inc.	Addex Convenes Extraordinary General Meeting	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/11/23	15:00	GlobeNewswire Inc.	Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/11/14	15:00	GlobeNewswire Inc.	Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/11/08	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ADXN	Addex Therapeutics Ltd
2023/11/08	15:00	GlobeNewswire Inc.	Addex Regains Nasdaq Listing Compliance	NASDAQ:ADXN	Addex Therapeutics Ltd

검색 관련기사 보기:NASDAQ:ADXN

1 2 3 4 5 6 7 8 9 다음 >>

Vontobel Financial Produ...

Central Del Latte Di Tor...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관